Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorder.

• Authors: J J Sramek, J F Costa, J B Adams, A Macpherson, N R Cutler
• Journal: Anxiety (Anxiety) 1994-1995 Vol. 1 Issue 5 Pg. 242-3 ISSN: 1070-9797 [Print] United States
• PMID: 9160582 (Publication Type: Clinical Trial, Letter, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Anti-Anxiety Agents
• Indoles
• Receptor, Cholecystokinin B
• Receptors, Cholecystokinin
• PD 134308
• Meglumine

Topics

• Adolescent
• Adult
• Anti-Anxiety Agents (adverse effects, therapeutic use)
• Anxiety Disorders (drug therapy)
• Double-Blind Method
• Female
• Humans
• Indoles (adverse effects, therapeutic use)
• Male
• Meglumine (adverse effects, analogs & derivatives, therapeutic use)
• Middle Aged
• Receptor, Cholecystokinin B
• Receptors, Cholecystokinin (antagonists & inhibitors)
• Treatment Outcome